Trials / Completed
CompletedNCT03430128
Perioperative Immunonutrition for Patients Undergoing CRS and HIPEC
Perioperative Immunonutrition for Patients Undergoing Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (actual)
- Sponsor
- National Cancer Centre, Singapore · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
Patients with peritoneal disease commonly present with symptoms of abdominal distension and subacute intestinal obstruction. This results in poor oral intake leading to these patients often presenting in a malnourished state. CRS and HIPEC can potential provide improve survival for these patients, however can be a hazardous procedure, involving multi-organ resections. The risk is especially high in poorly nourished patients. The study investigators hypothesize that perioperative immunonutrition can reduce wound infections and length of hospital stay, and improve perioperative outcomes. To the investigators' knowledge, it has not been evaluated in patients undergoing CRS and HIPEC.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | IMPACT immunotherapy | Powdered formula that is pre-packaged in individual packets which the patients will be instructed to mix with water before consumption. |
| DIETARY_SUPPLEMENT | ENSURE | Liquid milk formula available over the counter |
Timeline
- Start date
- 2017-04-23
- Primary completion
- 2019-01-22
- Completion
- 2019-01-22
- First posted
- 2018-02-12
- Last updated
- 2019-09-20
Locations
1 site across 1 country: Singapore
Source: ClinicalTrials.gov record NCT03430128. Inclusion in this directory is not an endorsement.